Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity
Conclusions:
SBRT for HCC is well-tolerated even in patients with advanced cirrhosis and prior liver-directed treatment and provides excellent LC even for larger lesions that cannot be controlled with radiofrequency ablation. LC with SBRT compares favorably to other liver-directed therapies. Prospective studies comparing SBRT with other liver-directed therapies are warranted.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Cancer & Oncology | Carcinoma | Children | Cirrhosis | CT Scan | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | MRI Scan | Pain | Radiation Therapy | Study | Toxicology | Urology & Nephrology